Hippocampus

Human neural stem cells may improve thinking and support brain connections in two mouse models of Alzheimer's and nerve cell loss

Updated

Abstract

Over 35 million people worldwide are affected by (AD), characterized by the accumulation of β-amyloid plaques and neurofibrillary tangles.

  • Transplantation of human (HuCNS-SCs) shows promise in improving cognition in two models of neurodegeneration.
  • HuCNS-SCs can migrate and differentiate into immature neurons and glial cells.
  • Significant increases in synaptic and growth-associated markers were observed in both the 3xTg-AD and CaM/Tet-DTA mouse models.
  • Cognitive improvements in aged 3xTg-AD mice occurred without changes in β-amyloid or tau pathology.
  • The findings suggest that human neural stem cell transplantation may enhance natural synaptogenesis to improve cognition.

Simplified

Key numbers

16.3 ± 4.04 s vs. 36.3 ± 7.0 s
Probe Trial Latency Decrease
Comparison of latency to reach hidden platform in Morris water maze.
4.0 ± 1.0 vs. 1.4 ± 0.4 times
Increased Platform Crosses
Frequency of crossing former platform location in Morris water maze.
36,600 cells per hippocampus in 3xTg- mice
Surviving HuCNS-SC Cells
Average number of surviving HuCNS-SC cells post-transplantation.

Full Text

What this is

  • () affects over 35 million people globally, characterized by cognitive decline due to neuronal loss.
  • Current therapies fail to alter progression, necessitating innovative treatments.
  • This study investigates the effects of human neural stem cell (HuCNS-SC) transplantation on cognition and synaptic growth in transgenic models.

Essence

  • Transplantation of human (HuCNS-SC) improves cognitive function and promotes synaptic growth in two transgenic models of without altering amyloid or tau pathology.

Key takeaways

  • HuCNS-SC transplantation significantly enhances cognitive performance in 3xTg- mice, as evidenced by faster probe trial latencies and increased platform crosses in the Morris water maze.
  • In both 3xTg- and CaM/Tet-DTA mice, HuCNS-SC transplantation leads to increased levels of synaptic markers, indicating enhanced synaptic connectivity.
  • Despite improvements in cognition and synaptic growth, HuCNS-SC transplantation does not affect levels of amyloid or tau pathology, suggesting a mechanism of action that operates independently of these factors.

Caveats

  • The study relies on transgenic mouse models, which may not fully replicate human pathology and responses.
  • The long-term effects and safety of HuCNS-SC transplantation in humans remain to be evaluated in future clinical trials.

Definitions

  • Alzheimer's disease (AD): A progressive neurodegenerative disorder marked by cognitive decline and characterized by amyloid plaques and tau tangles.
  • Neural stem cells (NSCs): Undifferentiated cells with the potential to develop into various types of neural cells, including neurons and glia.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free